Lesson plan

Celsense

Celsense, Inc. (2005-2021) was a privately held biotechnology company which developed imaging agents used to non-invasively detect and monitor cells and cellular activity. The company was based in Pittsburgh, Pennsylvania. Celsense was founded in 2005 to commercialize imaging platforms developed at Carnegie Mellon University. The CEO and president for the lifetime of the company was Charles O'Hanlon. In 2011, Celsense received FDA authorization to begin Phase I clinical trials for a colorectal cancer treatment using therapeutic dendritic cells. The company ceased operations on December 31, 2021.

Back to article

Article summary

Celsense, Inc. (2005-2021) was a privately held biotechnology company which developed imaging agents used to non-invasively detect and monitor cells and cellular activity. The company was based in Pittsburgh, Pennsylvania. Celsense was founded in 2005 to commercialize imaging platforms developed at Carnegie Mellon University. The CEO and president for the lifetime of the company was Charles O'Hanlon. In 2011, Celsense received FDA authorization to begin Phase I clinical trials for a colorectal cancer treatment using therapeutic dendritic cells. The company ceased operations on December 31, 2021.

Key claims

  1. date of foundation: 2005 — source: Wikipedia · confidence 0.95

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. The record states that the date of foundation is "2005". What evidence would count against this claim?
  3. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  4. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

  1. Wikipedia https://en.wikipedia.org/w/index.php?oldid=1357292239

Key claims and bibliography are generated from the same tracked claims and sources as the article page.